Global Animal Antibiotics and Antimicrobials Market
Global Animal Antibiotics and Antimicrobials Market

Animal Antibiotics and Antimicrobials Comprehensive Study by Type (Etracyclines, Penicillins, Macrolides, Aminoglycosides, Sulfonamides, Fluoroquinolones, Lincosamides, Cephalosporins, Other), Application (Food-producing Animals, Companion Animals) Players and Region - Global Market Outlook to 2024

Animal Antibiotics and Antimicrobials Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

May 2019 Edition 239 Pages 190 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Animal Antibiotics and Antimicrobials Market Scope
Increasing demand for pet insurance, rising animal health spending and Growing demand for animal-derived food products will help to fuel Animal Antibiotics and Antimicrobials in the forecasted period. Animal antibiotics and antimicrobials can be used in those animals which contribute to the development of antimicrobial resistance in bacteria that may be transmitted to persons, there for it decreases the efficiency of antimicrobial drugs for handling the human disease. Growing initiatives regarding animal health and welfare are anticipated to support the whole global market for animal antimicrobials and antibiotics.

The market study is being classified by Type (Etracyclines, Penicillins, Macrolides, Aminoglycosides, Sulfonamides, Fluoroquinolones, Lincosamides, Cephalosporins and Other), by Application (Food-producing Animals and Companion Animals) and major geographies with country level break-up.

Research Analyst at AMA predicts that United States and Europeam Players will contribute to the maximum growth of Global Animal Antibiotics and Antimicrobials market throughout the predicted period.

Zoetis, Inc. (United States), Merck & Co., Inc. (United States), Bayer AG (Germany), Eli Lilly and Company (United States), Virbac (France), Zoetis, Inc. (United States), Bayer AG (Germany), Merck & Co., Inc. (United States), Eli Lilly and Company (United States) and Virbac (France) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Boehringer Ingelheim GmbH (Germany), Ceva Sante Animale (France), Vetoquinol S.A. (France), Sanofi (France) and Dechra Pharmaceuticals PLC (United Kingdom).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Animal Antibiotics and Antimicrobials market by Type, Application and Region.

On the basis of geography, the market of Animal Antibiotics and Antimicrobials has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Market Trend
  • Rising Instances of Zoonotic Diseases will further Increase the Adoption
  • Continues Increase in Animal Health Expenditure

Market Drivers
  • Increasing Demand for Food Products Derived from Animals
  • Favorable Government Regulations in Preventing the Spread of Animal Diseases

Opportunities
  • Upsurging Demand from the Untapped Emerging Economies
  • Robustly Growing Population for Companion Animals may further Increase the Demand

Restraints
  • Growing Threat of Substitutes such as New Antibiotics as well as it can be replaced by Good Husbandry and Hygiene Practices
  • Due to Increased Consumption, Growing Resistance Concerns to Antimicrobials and Antibiotics

Challenges
  • Complex and Lengthy Approval Process for Antimicrobials and Antibiotics


Key Target Audience
Animal Antibiotics and Antimicrobials Manufacturers, Animal Antibiotics and Antimicrobials Distributors and Traders, Upstream and Downstream Buyers, Government Agencies, Healthcare Industry Associations, Venture Capitalist, Animal Based Industry Associations and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Etracyclines
  • Penicillins
  • Macrolides
  • Aminoglycosides
  • Sulfonamides
  • Fluoroquinolones
  • Lincosamides
  • Cephalosporins
  • Other
By Application
  • Food-producing Animals
  • Companion Animals
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Food Products Derived from Animals
      • 3.2.2. Favorable Government Regulations in Preventing the Spread of Animal Diseases
    • 3.3. Market Challenges
      • 3.3.1. Complex and Lengthy Approval Process for Antimicrobials and Antibiotics
    • 3.4. Market Trends
      • 3.4.1. Rising Instances of Zoonotic Diseases will further Increase the Adoption
      • 3.4.2. Continues Increase in Animal Health Expenditure
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Animal Antibiotics and Antimicrobials, by Type, Application and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Animal Antibiotics and Antimicrobials (Value)
      • 5.2.1. Global Animal Antibiotics and Antimicrobials by: Type (Value)
        • 5.2.1.1. Etracyclines
        • 5.2.1.2. Penicillins
        • 5.2.1.3. Macrolides
        • 5.2.1.4. Aminoglycosides
        • 5.2.1.5. Sulfonamides
        • 5.2.1.6. Fluoroquinolones
        • 5.2.1.7. Lincosamides
        • 5.2.1.8. Cephalosporins
        • 5.2.1.9. Other
      • 5.2.2. Global Animal Antibiotics and Antimicrobials by: Application (Value)
        • 5.2.2.1. Food-producing Animals
        • 5.2.2.2. Companion Animals
      • 5.2.3. Global Animal Antibiotics and Antimicrobials Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Animal Antibiotics and Antimicrobials: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zoetis, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck & Co., Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bayer AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Eli Lilly and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Virbac (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Zoetis, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bayer AG (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Merck & Co., Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Eli Lilly and Company (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Virbac (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Animal Antibiotics and Antimicrobials Sale, by Type, Application and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Animal Antibiotics and Antimicrobials (Value)
      • 7.2.1. Global Animal Antibiotics and Antimicrobials by: Type (Value)
        • 7.2.1.1. Etracyclines
        • 7.2.1.2. Penicillins
        • 7.2.1.3. Macrolides
        • 7.2.1.4. Aminoglycosides
        • 7.2.1.5. Sulfonamides
        • 7.2.1.6. Fluoroquinolones
        • 7.2.1.7. Lincosamides
        • 7.2.1.8. Cephalosporins
        • 7.2.1.9. Other
      • 7.2.2. Global Animal Antibiotics and Antimicrobials by: Application (Value)
        • 7.2.2.1. Food-producing Animals
        • 7.2.2.2. Companion Animals
      • 7.2.3. Global Animal Antibiotics and Antimicrobials Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Animal Antibiotics and Antimicrobials: by Type(USD Million)
  • Table 2. Animal Antibiotics and Antimicrobials Etracyclines , by Region USD Million (2013-2018)
  • Table 3. Animal Antibiotics and Antimicrobials Penicillins , by Region USD Million (2013-2018)
  • Table 4. Animal Antibiotics and Antimicrobials Macrolides , by Region USD Million (2013-2018)
  • Table 5. Animal Antibiotics and Antimicrobials Aminoglycosides , by Region USD Million (2013-2018)
  • Table 6. Animal Antibiotics and Antimicrobials Sulfonamides , by Region USD Million (2013-2018)
  • Table 7. Animal Antibiotics and Antimicrobials Fluoroquinolones , by Region USD Million (2013-2018)
  • Table 8. Animal Antibiotics and Antimicrobials Lincosamides , by Region USD Million (2013-2018)
  • Table 9. Animal Antibiotics and Antimicrobials Cephalosporins , by Region USD Million (2013-2018)
  • Table 10. Animal Antibiotics and Antimicrobials Other , by Region USD Million (2013-2018)
  • Table 11. Animal Antibiotics and Antimicrobials: by Application(USD Million)
  • Table 12. Animal Antibiotics and Antimicrobials Food-producing Animals , by Region USD Million (2013-2018)
  • Table 13. Animal Antibiotics and Antimicrobials Companion Animals , by Region USD Million (2013-2018)
  • Table 14. South America Animal Antibiotics and Antimicrobials, by Country USD Million (2013-2018)
  • Table 15. South America Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 16. South America Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 17. Brazil Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 18. Brazil Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 19. Argentina Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 20. Argentina Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 21. Rest of South America Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 22. Rest of South America Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 23. Asia Pacific Animal Antibiotics and Antimicrobials, by Country USD Million (2013-2018)
  • Table 24. Asia Pacific Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 25. Asia Pacific Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 26. China Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 27. China Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 28. Japan Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 29. Japan Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 30. India Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 31. India Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 32. South Korea Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 33. South Korea Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 34. Taiwan Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 35. Taiwan Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 36. Australia Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 37. Australia Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 38. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 39. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 40. Europe Animal Antibiotics and Antimicrobials, by Country USD Million (2013-2018)
  • Table 41. Europe Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 42. Europe Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 43. Germany Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 44. Germany Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 45. France Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 46. France Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 47. Italy Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 48. Italy Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 49. United Kingdom Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 50. United Kingdom Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 51. Netherlands Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 52. Netherlands Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 53. Rest of Europe Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 54. Rest of Europe Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 55. MEA Animal Antibiotics and Antimicrobials, by Country USD Million (2013-2018)
  • Table 56. MEA Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 57. MEA Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 58. Middle East Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 59. Middle East Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 60. Africa Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 61. Africa Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 62. North America Animal Antibiotics and Antimicrobials, by Country USD Million (2013-2018)
  • Table 63. North America Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 64. North America Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 65. United States Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 66. United States Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 67. Canada Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 68. Canada Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 69. Mexico Animal Antibiotics and Antimicrobials, by Type USD Million (2013-2018)
  • Table 70. Mexico Animal Antibiotics and Antimicrobials, by Application USD Million (2013-2018)
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Animal Antibiotics and Antimicrobials: by Type(USD Million)
  • Table 82. Animal Antibiotics and Antimicrobials Etracyclines , by Region USD Million (2019-2024)
  • Table 83. Animal Antibiotics and Antimicrobials Penicillins , by Region USD Million (2019-2024)
  • Table 84. Animal Antibiotics and Antimicrobials Macrolides , by Region USD Million (2019-2024)
  • Table 85. Animal Antibiotics and Antimicrobials Aminoglycosides , by Region USD Million (2019-2024)
  • Table 86. Animal Antibiotics and Antimicrobials Sulfonamides , by Region USD Million (2019-2024)
  • Table 87. Animal Antibiotics and Antimicrobials Fluoroquinolones , by Region USD Million (2019-2024)
  • Table 88. Animal Antibiotics and Antimicrobials Lincosamides , by Region USD Million (2019-2024)
  • Table 89. Animal Antibiotics and Antimicrobials Cephalosporins , by Region USD Million (2019-2024)
  • Table 90. Animal Antibiotics and Antimicrobials Other , by Region USD Million (2019-2024)
  • Table 91. Animal Antibiotics and Antimicrobials: by Application(USD Million)
  • Table 92. Animal Antibiotics and Antimicrobials Food-producing Animals , by Region USD Million (2019-2024)
  • Table 93. Animal Antibiotics and Antimicrobials Companion Animals , by Region USD Million (2019-2024)
  • Table 94. South America Animal Antibiotics and Antimicrobials, by Country USD Million (2019-2024)
  • Table 95. South America Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 96. South America Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 97. Brazil Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 98. Brazil Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 99. Argentina Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 100. Argentina Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 101. Rest of South America Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 102. Rest of South America Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 103. Asia Pacific Animal Antibiotics and Antimicrobials, by Country USD Million (2019-2024)
  • Table 104. Asia Pacific Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 105. Asia Pacific Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 106. China Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 107. China Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 108. Japan Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 109. Japan Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 110. India Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 111. India Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 112. South Korea Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 113. South Korea Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 114. Taiwan Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 115. Taiwan Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 116. Australia Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 117. Australia Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 118. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 119. Rest of Asia-Pacific Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 120. Europe Animal Antibiotics and Antimicrobials, by Country USD Million (2019-2024)
  • Table 121. Europe Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 122. Europe Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 123. Germany Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 124. Germany Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 125. France Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 126. France Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 127. Italy Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 128. Italy Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 129. United Kingdom Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 130. United Kingdom Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 131. Netherlands Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 132. Netherlands Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 133. Rest of Europe Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 134. Rest of Europe Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 135. MEA Animal Antibiotics and Antimicrobials, by Country USD Million (2019-2024)
  • Table 136. MEA Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 137. MEA Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 138. Middle East Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 139. Middle East Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 140. Africa Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 141. Africa Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 142. North America Animal Antibiotics and Antimicrobials, by Country USD Million (2019-2024)
  • Table 143. North America Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 144. North America Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 145. United States Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 146. United States Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 147. Canada Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 148. Canada Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 149. Mexico Animal Antibiotics and Antimicrobials, by Type USD Million (2019-2024)
  • Table 150. Mexico Animal Antibiotics and Antimicrobials, by Application USD Million (2019-2024)
  • Table 151. Research Programs/Design for This Report
  • Table 152. Key Data Information from Secondary Sources
  • Table 153. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Animal Antibiotics and Antimicrobials: by Type USD Million (2013-2018)
  • Figure 5. Global Animal Antibiotics and Antimicrobials: by Application USD Million (2013-2018)
  • Figure 6. South America Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 7. Asia Pacific Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 8. Europe Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 9. MEA Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 10. North America Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 11. Global Animal Antibiotics and Antimicrobials share by Players 2018 (%)
  • Figure 12. Global Animal Antibiotics and Antimicrobials share by Players (Top 3) 2018(%)
  • Figure 13. Global Animal Antibiotics and Antimicrobials share by Players (Top 5) 2018(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Zoetis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 16. Zoetis, Inc. (United States) Revenue: by Geography 2018
  • Figure 17. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Merck & Co., Inc. (United States) Revenue: by Geography 2018
  • Figure 19. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Bayer AG (Germany) Revenue: by Geography 2018
  • Figure 21. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 22. Eli Lilly and Company (United States) Revenue: by Geography 2018
  • Figure 23. Virbac (France) Revenue, Net Income and Gross profit
  • Figure 24. Virbac (France) Revenue: by Geography 2018
  • Figure 25. Zoetis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Zoetis, Inc. (United States) Revenue: by Geography 2018
  • Figure 27. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Bayer AG (Germany) Revenue: by Geography 2018
  • Figure 29. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Merck & Co., Inc. (United States) Revenue: by Geography 2018
  • Figure 31. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 32. Eli Lilly and Company (United States) Revenue: by Geography 2018
  • Figure 33. Virbac (France) Revenue, Net Income and Gross profit
  • Figure 34. Virbac (France) Revenue: by Geography 2018
  • Figure 35. Global Animal Antibiotics and Antimicrobials: by Type USD Million (2019-2024)
  • Figure 36. Global Animal Antibiotics and Antimicrobials: by Application USD Million (2019-2024)
  • Figure 37. South America Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 38. Asia Pacific Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 39. Europe Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 40. MEA Animal Antibiotics and Antimicrobials Share (%), by Country
  • Figure 41. North America Animal Antibiotics and Antimicrobials Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Zoetis, Inc. (United States)
  • Merck & Co., Inc. (United States)
  • Bayer AG (Germany)
  • Eli Lilly and Company (United States)
  • Virbac (France)
  • Zoetis, Inc. (United States)
  • Bayer AG (Germany)
  • Merck & Co., Inc. (United States)
  • Eli Lilly and Company (United States)
  • Virbac (France)
Additional players considered in the study are as follows:
Boehringer Ingelheim GmbH (Germany) , Ceva Sante Animale (France) , Vetoquinol S.A. (France) , Sanofi (France) , Dechra Pharmaceuticals PLC (United Kingdom)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation